Hyris Brings to Market Worldwide a New Test That Can Quickly Detect the Body’s T-Cell Immune Response to SARS-CoV-2, Thanks to a Partnership With Singapore’s Duke-NUS Medical

Hyris developed a rapid T-cell test to track patients’ immunity levels to SARS-CoV-2 for global clinical use after having inked an exclusive licensing agreement with Duke-NUS Medical School. This new solution leverages the Hyris SystemTM, a proprietary platform that enables

Read More